Evidence map›Paper›PMID 33519215›Full record

ArticleInfection and drug resistance2021

Prevalence of Aminoglycoside Resistance and Aminoglycoside Modifying Enzymes in

Rania Kishk, Nourhan Soliman, Nader Nemr, Raghda Eldesouki, Nageh Mahrous, Adil Gobouri, Ehab Azab, Maha Anani

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Virulence · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Signaling inComputational and structural biotechnology journal · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genotypic Patterns of Multidrug-ResistantAdvanced biomedical research · 2023
    Review
  14. Molecular characterization of multidrug resistantFrontiers in cellular and infection microbiology · 2023
    Article
  15. Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2023
    Review
  16. Article
  17. Review
  18. Detection of theArchives of Razi Institute · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Rania KishkMicrobiology and Immunology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.ORCID 0000-0002-8235-3103
Nourhan SolimanClinical Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Nader NemrEndemic and Infectious Diseases Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Raghda EldesoukiGenetics Unit, Histology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.ORCID 0000-0002-8860-3484
Nageh MahrousEndemic and Infectious Diseases Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Adil GobouriDepartment of Chemistry, College of Science, Taif University, Taif 21944, Saudi Arabia.
Ehab AzabDepartment of Biotechnology, College of Science, Taif University, Taif 21944, Saudi Arabia.ORCID 0000-0002-1122-3942
Maha AnaniClinical Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Suez Canal University · EGTaif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

aimThis study aimed to provide an insight into the frequency of genes encoding AME in METHODOLOGY: A total of 52 multidrug-resistant (MDR)

resultsAminoglycosides resistance (amikacin, gentamicin and tobramycin) was observed in 35 isolates (67.3%). We found that aacC1 gene was the predominant AME resistance gene among

conclusionOur study indicated that AME encoding genes are predominant in

Indexed as

aacC1aadA1aadBAcinetobacter baumanniiaminoglycoside-modifying enzymes; AMEaphA6

Identifiers

PMID33519215
PMCPMC7838519
OpenAlexW3121563876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.